Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Enterprise Value to FCFF (EV/FCFF)

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Free Cash Flow to The Firm (FCFF)

Medtronic PLC, FCFF calculation

US$ in millions

Microsoft Excel
12 months ended: Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Net income attributable to Medtronic
Net income attributable to noncontrolling interests
Net noncash charges
Change in operating assets and liabilities, net of acquisitions and divestitures
Net cash provided by operating activities
Cash paid for interest, net of tax1
Additions to property, plant, and equipment
Free cash flow to the firm (FCFF)

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The cash flow profile exhibits a period of volatility between 2021 and 2023, followed by a sustained recovery phase. While both net cash provided by operating activities and free cash flow to the firm (FCFF) experienced a notable contraction in the 2023 fiscal year, subsequent periods indicate a consistent return to growth, with figures approaching 2022 levels by 2026.

Operating Cash Flow Trends
Net cash provided by operating activities peaked in 2022 at 7,346 million US$, representing a significant increase from the 6,240 million US$ recorded in 2021. A sharp decline occurred in 2023, where cash flow dropped to 6,039 million US$, before entering a steady growth phase that reaches 7,330 million US$ by 2026.
Free Cash Flow to the Firm (FCFF) Performance
FCFF closely mirrors the trajectory of operating cash flow, reaching a high of 6,473 million US$ in 2022 before falling to a period low of 5,007 million US$ in 2023. From 2024 through 2026, FCFF demonstrates a moderate recovery, stabilizing and eventually reaching 6,036 million US$, although it remains below the 2022 peak.
Cash Conversion and Capital Expenditure Patterns
A consistent gap is observed between operating cash flow and FCFF, reflecting the impact of capital expenditures. Analysis of this gap indicates a shift in capital allocation; between 2024 and 2026, operating cash flow grew by approximately 533 million US$, while FCFF grew by only 203 million US$. This divergence suggests an increasing proportion of operating cash is being directed toward capital investments in the latter part of the period.


Interest Paid, Net of Tax

Medtronic PLC, interest paid, net of tax calculation

US$ in millions

Microsoft Excel
12 months ended: Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Effective Income Tax Rate (EITR)
EITR1
Interest Paid, Net of Tax
Cash paid for interest, before tax
Less: Cash paid for interest, tax2
Cash paid for interest, net of tax

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 See details »

2 2026 Calculation
Cash paid for interest, tax = Cash paid for interest × EITR
= × =


The financial trajectory of net interest payments and the effective income tax rate exhibits significant volatility between April 2021 and April 2026, characterized by a distinct U-shaped trend in cash outflows and erratic tax rate fluctuations.

Net Interest Cash Outflow Trends
Cash paid for interest, net of tax, decreased steadily from 542 million USD in 2021 to a period low of 427 million USD in 2023. This downward trend was followed by a substantial increase in 2024, where payments rose to 633 million USD. The expenditure remained relatively plateaued in 2025 at 636 million USD before experiencing a slight contraction to 610 million USD in 2026.
Effective Income Tax Rate (EITR) Analysis
The EITR demonstrated high variability over the analyzed timeframe. After starting at 6.80% in 2021 and 8.30% in 2022, the rate spiked to a peak of 29.50% in 2023. A subsequent decline occurred over the next two years, reaching 16.60% in 2025, followed by a modest recovery to 21.20% in 2026.
Correlation Between Tax Rates and Net Interest Costs
An inverse relationship is observed between the EITR and net interest payments during the 2023 fiscal year. The peak tax rate of 29.50% coincides with the lowest net interest payment of 427 million USD, indicating that the increased tax shield significantly reduced the net cash impact of interest expenses. Conversely, as the tax rate normalized in 2024 and 2025, the net cash paid for interest reached its highest levels in the series.


Enterprise Value to FCFF Ratio, Current

Medtronic PLC, current EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in millions)
Enterprise value (EV)
Free cash flow to the firm (FCFF)
Valuation Ratio
EV/FCFF
Benchmarks
EV/FCFF, Competitors1
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
EV/FCFF, Sector
Health Care Equipment & Services
EV/FCFF, Industry
Health Care

Based on: 10-K (reporting date: 2026-04-24).

1 Click competitor name to see calculations.

If the company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if the company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.



Enterprise Value to FCFF Ratio, Historical

Medtronic PLC, historical EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Enterprise value (EV)1
Free cash flow to the firm (FCFF)2
Valuation Ratio
EV/FCFF3
Benchmarks
EV/FCFF, Competitors4
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
EV/FCFF, Sector
Health Care Equipment & Services
EV/FCFF, Industry
Health Care

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 See details »

2 See details »

3 2026 Calculation
EV/FCFF = EV ÷ FCFF
= ÷ =

4 Click competitor name to see calculations.


The valuation multiple based on Enterprise Value to Free Cash Flow to the Firm (EV/FCFF) exhibits a significant initial contraction followed by a period of relative stabilization. A peak ratio of 33.84 in 2021 decreased sharply to 20.32 by 2022, indicating a substantial correction in market valuation relative to the entity's cash flow generation capacity.

Enterprise Value Dynamics
A notable reduction in Enterprise Value occurred between April 2021 and April 2022, with the value falling from 183,640 million to 131,529 million. Following this decline, the value entered a period of consolidation, fluctuating within a range of approximately 120,000 million to 130,000 million through the 2026 projection period.
Free Cash Flow to the Firm (FCFF) Trends
FCFF demonstrated moderate volatility, peaking at 6,473 million in 2022 before experiencing a trough of 5,007 million in 2023. A recovery trend is observed from 2024 onward, with cash flows stabilizing and eventually reaching a projected 6,036 million by 2026, suggesting a consistent underlying ability to generate cash.
EV/FCFF Ratio Interpretation
The ratio underwent a sharp decline of approximately 40% between 2021 and 2022. While a temporary increase to 26.54 was recorded in 2023, the multiple has since converged toward a baseline of approximately 20x. This trend indicates that the market valuation has transitioned from a highly optimistic premium in 2021 to a more conservative and stable alignment with actual cash flow performance.